{
    "2018-08-15": [
        [
            {
                "time": "",
                "original_text": "上半年超七成医药股净利润上涨 这三家药企排名前三",
                "features": {
                    "keywords": [
                        "医药股",
                        "净利润",
                        "上涨"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[推荐评级]恒瑞医药(600276)半年报点评：业绩稳定增长 重磅品种陆续步入收获期",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "半年报",
                        "业绩",
                        "稳定增长",
                        "重磅品种"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[增持评级]“大医保”动态跟踪系列报告之一：医保局应运而生 系列新政呼之欲出",
                "features": {
                    "keywords": [
                        "大医保",
                        "医保局",
                        "新政"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "333亿资金恐慌逃离 五类股遭主力机构抛",
                "features": {
                    "keywords": [
                        "资金",
                        "恐慌逃离",
                        "主力机构",
                        "抛售"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "全市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "A股“进化论”新方法 成长股估值体系重塑",
                "features": {
                    "keywords": [
                        "A股",
                        "进化论",
                        "成长股",
                        "估值体系"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "全市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "5亿研发、挑战赫赛汀 恒瑞重磅新药昨日上市",
                "features": {
                    "keywords": [
                        "恒瑞",
                        "研发",
                        "新药",
                        "上市"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "恒瑞医药股价大跌-5.01%",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "股价",
                        "大跌"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "7月医药大事件之榜单篇：肯定药企成绩 提供发展动力",
                "features": {
                    "keywords": [
                        "医药",
                        "大事",
                        "药企",
                        "成绩",
                        "发展动力"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医疗保健：14种抗癌药将迎新一波降价 荐12股",
                "features": {
                    "keywords": [
                        "医疗保健",
                        "抗癌药",
                        "降价"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【陆股通交易追踪】陆股通净流出13.4亿元 食品饮料板块遭减仓",
                "features": {
                    "keywords": [
                        "陆股通",
                        "净流出",
                        "食品饮料",
                        "减仓"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "食品饮料"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "【财通医药】恒瑞医药(600276)：业绩符合预期，创新+仿制+国际化",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "业绩",
                        "创新",
                        "仿制",
                        "国际化"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "三大数据揭秘外资新动向 QFII二季度增仓21只个股",
                "features": {
                    "keywords": [
                        "外资",
                        "QFII",
                        "增仓",
                        "个股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "全市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}